{"id":"https://openalex.org/W631659599","doi":null,"title":"Selective Acceleration of CRLF2+Lymphoblast Phagocytosis with CD47siRNA-Loaded Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles","display_name":"Selective Acceleration of CRLF2+Lymphoblast Phagocytosis with CD47siRNA-Loaded Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles","publication_year":2014,"publication_date":"2014-12-31","ids":{"openalex":"https://openalex.org/W631659599","mag":"631659599"},"language":"en","primary_location":{"id":"mag:631659599","doi":null,"is_oa":false,"landing_page_url":"http://www.scipublish.com/journals/ABSE/papers/download/3402-962.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210185953","display_name":"Advances in Biomedical Science and Engineering","issn_l":"2377-035X","issn":["2377-035X","2377-0376"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Advances in Biomedical Science and Engineering","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003038563","display_name":"William E. Haskins","orcid":"https://orcid.org/0000-0001-7972-2142","observed_orcids":["https://orcid.org/0000-0001-7972-2142"]},"institutions":[{"id":"https://openalex.org/I164936912","display_name":"The University of Texas at El Paso","ror":"https://ror.org/04d5vba33","country_code":"US","type":"education","lineage":["https://openalex.org/I164936912"]},{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William E. Haskins","raw_affiliation_strings":["Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249, Border Biomedical Research Center; University of Texas at El Paso, El Paso, TX, 79968"],"raw_orcid":"https://orcid.org/0000-0001-7972-2142","affiliations":[{"raw_affiliation_string":"Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249, Border Biomedical Research Center; University of Texas at El Paso, El Paso, TX, 79968","institution_ids":["https://openalex.org/I164936912","https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044066095","display_name":"Kelly L. Nash","orcid":"https://orcid.org/0000-0001-8235-9479","observed_orcids":["https://orcid.org/0000-0001-8235-9479"]},"institutions":[{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Nash","raw_affiliation_strings":["Department of Physics, University of Texas at San Antonio, San Antonio, TX, 78249"],"raw_orcid":"https://orcid.org/0000-0001-8235-9479","affiliations":[{"raw_affiliation_string":"Department of Physics, University of Texas at San Antonio, San Antonio, TX, 78249","institution_ids":["https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052384451","display_name":"Swetha Mahesula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swetha Mahesula","raw_affiliation_strings":["Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249","institution_ids":["https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064294367","display_name":"Rekha Raghunathan","orcid":"https://orcid.org/0000-0003-0778-1973","observed_orcids":["https://orcid.org/0000-0003-0778-1973"]},"institutions":[{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rekha Raghunathan","raw_affiliation_strings":["Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249"],"raw_orcid":"https://orcid.org/0000-0003-0778-1973","affiliations":[{"raw_affiliation_string":"Pediatric Biochemistry Laboratory, University of Texas at San Antonio, San Antonio, TX, 78249","institution_ids":["https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074630961","display_name":"Alexis Catala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis Catala","raw_affiliation_strings":["Department of Physics, University of Texas at San Antonio, San Antonio, TX, 78249"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physics, University of Texas at San Antonio, San Antonio, TX, 78249","institution_ids":["https://openalex.org/I45438204"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027085103","display_name":"Robert Arthur Kirken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164936912","display_name":"The University of Texas at El Paso","ror":"https://ror.org/04d5vba33","country_code":"US","type":"education","lineage":["https://openalex.org/I164936912"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Kirken","raw_affiliation_strings":["Border Biomedical Research Center; University of Texas at El Paso, El Paso, TX, 79968"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Border Biomedical Research Center; University of Texas at El Paso, El Paso, TX, 79968","institution_ids":["https://openalex.org/I164936912"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"2","first_page":"12","last_page":"19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.7851999998092651,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.7851999998092651,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.2061000019311905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crlf2","display_name":"CRLF2","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cd47","display_name":"CD47","score":0.7350000143051147},{"id":"https://openalex.org/keywords/sirna-delivery","display_name":"siRNA delivery","score":0.9430000185966492},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.9810000061988831},{"id":"https://openalex.org/keywords/biodegradable-nanoparticles","display_name":"biodegradable nanoparticles","score":0.718999981880188},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.8199999928474426},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.9629999995231628},{"id":"https://openalex.org/keywords/lymphoblasts","display_name":"lymphoblasts","score":0.875},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6340000033378601},{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.6420000195503235},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5479999780654907},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.6470000147819519}],"concepts":[{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6312978267669678},{"id":"https://openalex.org/C160448771","wikidata":"https://www.wikidata.org/wiki/Q184726","display_name":"Phagocytosis","level":2,"score":0.5204089879989624},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.512332558631897},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48640158772468567},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47287365794181824},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4512627422809601},{"id":"https://openalex.org/C113842279","wikidata":"https://www.wikidata.org/wiki/Q1873857","display_name":"Lymphoblast","level":3,"score":0.4324285089969635},{"id":"https://openalex.org/C2780104668","wikidata":"https://www.wikidata.org/wiki/Q21108354","display_name":"CD47","level":3,"score":0.42863929271698},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32079243659973145},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2943286597728729},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27891939878463745},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20645886659622192},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19594165682792664},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14975625276565552},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10374388098716736},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:631659599","doi":null,"is_oa":false,"landing_page_url":"http://www.scipublish.com/journals/ABSE/papers/download/3402-962.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210185953","display_name":"Advances in Biomedical Science and Engineering","issn_l":"2377-035X","issn":["2377-035X","2377-0376"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Advances in Biomedical Science and Engineering","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1631519520","https://openalex.org/W1966649467","https://openalex.org/W1968663152","https://openalex.org/W1968937054","https://openalex.org/W1968949976","https://openalex.org/W1983875731","https://openalex.org/W1989940425","https://openalex.org/W2000076998","https://openalex.org/W2001570963","https://openalex.org/W2006595691","https://openalex.org/W2011164875","https://openalex.org/W2017697362","https://openalex.org/W2019980666","https://openalex.org/W2024353213","https://openalex.org/W2031162287","https://openalex.org/W2039949492","https://openalex.org/W2042973822","https://openalex.org/W2050074797","https://openalex.org/W2055588506","https://openalex.org/W2068491059","https://openalex.org/W2071700698","https://openalex.org/W2072623580","https://openalex.org/W2073116924","https://openalex.org/W2082195639","https://openalex.org/W2089881927","https://openalex.org/W2092705900","https://openalex.org/W2096828550","https://openalex.org/W2097126393","https://openalex.org/W2103746815","https://openalex.org/W2106545303","https://openalex.org/W2117630026","https://openalex.org/W2130869560","https://openalex.org/W2141638428","https://openalex.org/W2142541925","https://openalex.org/W2154672378","https://openalex.org/W2157830017","https://openalex.org/W2163574066"],"related_works":["https://openalex.org/W1989940425","https://openalex.org/W7214548724","https://openalex.org/W2052382519","https://openalex.org/W4413456629","https://openalex.org/W4415081933","https://openalex.org/W4283797929","https://openalex.org/W2038756260","https://openalex.org/W2009754313","https://openalex.org/W2587966174","https://openalex.org/W2302332867"],"abstract_inverted_index":{"Efforts":[0],"to":[1,13,113,120],"overcome":[2,128],"problems":[3,129],"associated":[4],"with":[5,21,98,130],"therapeutic":[6],"index,":[7],"resistance":[8,115],"and":[9,46,58,92,123,142],"toxicity":[10],"have":[11],"led":[12],"the":[14,50,143],"development":[15],"of":[16,49,68,77,147],"long-circulating,":[17],"drug-loaded,":[18],"polymeric":[19],"nanoparticles":[20,39],"antibody":[22],"targeting":[23],"agents.":[24],"Here":[25],"we":[26,83],"show":[27],"preliminary":[28],"characterization":[29],"results":[30],"for":[31,139],"CD47siRNA-loaded,":[32],"antiCRLF2-antibody-armored":[33],"biodegradable":[34],"poly":[35],"(D,":[36],"L-lactide-co-glycolide)":[37],"(PLGA)":[38],"(AbBNPs)":[40],"directed":[41],"against":[42],"CRLF2+lymphoblasts.":[43],"The":[44],"size":[45],"zeta":[47],"potential":[48],"AbBNPs":[51,73],"were":[52],"verified":[53],"using":[54],"scanning":[55],"electron":[56],"microscopy":[57],"dynamic":[59],"light":[60],"scattering.":[61],"Multi-color":[62],"flow":[63],"cytometry":[64],"revealed":[65],"that":[66,85,117],"silencing":[67],"CD47":[69],"by":[70,80],"CD47siRNA-loaded":[71],"anti-CRLF2":[72],"selectively":[74],"accelerates":[75],"phagocytosis":[76],"CRLF2+":[78],"blasts":[79],"macrophages.":[81],"Therefore,":[82],"posit":[84],"these":[86,125],"nanomedicines":[87,126],"might":[88,127],"be":[89],"significantly":[90],"safer":[91],"more":[93],"efficacious":[94],"than":[95],"combination":[96],"chemotherapies":[97],"cytotoxic":[99],"drugs,":[100],"anti-CD47":[101],"Abs":[102],"or":[103],"antiAb-drug":[104],"conjugates":[105],"(ADCs).":[106],"Future":[107],"directions":[108],"will":[109],"investigate":[110],"reduced":[111],"susceptibility":[112],"drug":[114],"mechanisms":[116],"can":[118],"lead":[119],"secondary":[121],"malignancies,":[122],"how":[124],"traditional":[131],"siRNA":[132],"delivery":[133],"schemes,":[134],"including":[135],"low":[136],"transfection":[137],"efficiency":[138],"non-adherent":[140],"CRLF2+blasts":[141],"short":[144],"circulation":[145],"half-life":[146],"siRNA.":[148]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}